/PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that.
CARLSBAD, Calif., March 29, 2023 /PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Rec.
HC Wainwright reiterated their buy rating on shares of Tyra Biosciences (NASDAQ:TYRA – Get Rating) in a report published on Thursday, Benzinga reports. The brokerage currently has a $17.00 price target on the stock. HC Wainwright also issued estimates for Tyra Biosciences’ Q1 2024 earnings at ($0.40) EPS, Q2 2024 earnings at ($0.44) EPS, Q3 […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) COO Daniel Bensen sold 3,800 shares of the company’s stock in a transaction that occurred on Wednesday, March 22nd. The stock was sold at an average price of $16.00, for a total transaction of $60,800.00. Following the completion of the transaction, the chief operating officer now owns 527,981 […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) COO Daniel Bensen sold 3,800 shares of Tyra Biosciences stock in a transaction dated Wednesday, March 22nd. The shares were sold at an average price of $16.00, for a total value of $60,800.00. Following the sale, the chief operating officer now owns 527,981 shares of the company’s stock, […]